LENZ Therapeutics, Inc.
LENZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,769 | -$69,968 | -$101,052 | -$70,760 |
| Dep. & Amort. | $58 | $15 | $8,346 | $734 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,365 | $1,343 | $0 | $0 |
| Change in WC | -$13,091 | $9,410 | -$7,208 | -$2,498 |
| Other Non-Cash | -$2,954 | -$1,180 | $11,934 | $19,672 |
| Operating Cash Flow | -$59,391 | -$60,380 | -$87,980 | -$52,852 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$468 | -$30 | -$6,594 | -$5,740 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$241,911 | -$52,091 | -$405,519 | $0 |
| Inv. Sales/Matur. | $87,900 | $22,500 | $170,250 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$154,479 | -$29,621 | -$241,863 | -$5,740 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $79,513 | $0 | $676 | $417,161 |
| Stock Repurch. | $0 | $0 | -$79 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $119,489 | -$2,276 | $0 | $306 |
| Financing Cash Flow | $199,002 | $80,700 | $597 | $417,467 |
| Forex Effect | $0 | $0 | $0 | -$1,716 |
| Net Chg. in Cash | -$14,868 | -$9,301 | -$329,246 | $357,159 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,140 | $44,441 | $376,976 | $19,817 |
| End Cash | $20,272 | $35,140 | $47,730 | $376,976 |
| Free Cash Flow | -$59,859 | -$60,410 | -$94,574 | -$58,592 |